Interleukin-6 and soluble intercellular adhesion molecule-1 in acute brain ischaemia

European Journal of Neurology

Volumn 15, Issue 4, 2008, Pages 323-328

  Orion, D ^a   Schwammenthal, Y ^a   Reshef, T ^b   Schwartz, R ^a   Tsabari, R ^a   Merzeliak, O ^a   Chapman, J ^a,c   Mekori, Y A ^b,c   Tanne, D ^a  

^a SHEBA MEDICAL CENTER   (Israel)

^b MEIR MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Inflammatory biomarkers; Interleukin 6; Soluble intercellular adhesion molecule 1; Stroke

Indexed keywords

BIOLOGICAL MARKER; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6;

ACUTE BRAIN DISEASE; ADULT; AGED; ARTICLE; BLOOD SAMPLING; BRAIN ISCHEMIA; CONCENTRATION RESPONSE; CONFIDENCE INTERVAL; DISABILITY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RANKIN SCALE; RATING SCALE; STROKE; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BRAIN ISCHEMIA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

EID: 41049094779     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2008.02066.x     Document Type: Article

References (31)

1. Feuerstein GZ, Wang X. Inflammation and stroke: benefits without harm? Archives of Neurology 2001 58 : 672 674.
2. Chamorro A. Role of inflammation in stroke and atherothrombosis. Cerebrovascular Diseases 2004 17 (Suppl. 3 1 5.
3. Ross R. Atherosclerosis - an inflammatory disease. The New England Journal of Medicine 1999 340 : 115 126.
4. Vila N, Filella X, Deulofeu R, Ascaso C, Abellana R, Chamorro A. Cytokine-induced inflammation and long-term stroke functional outcome. Journal of The Neurological Sciences 1999 162 : 185 188.
5. Ridker PM. Inflammatory biomarkers, statins, and the risk of stroke: cracking a clinical conundrum. Circulation 2002 105 : 2583 2585.
6. Castillo J, Leira R. Predictors of deteriorating cerebral infarct: role of inflammatory mechanisms. Would its early treatment be useful? Cerebrovascular Diseases 2001 11 (Suppl 1 40 48.
7. Vila N, Castillo J, Davalos A, Chamorro A. Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke 2000 31 : 2325 2329.
8. Vila N, Castillo J, Davalos A, Esteve A, Planas AM, Chamorro A. Levels of anti-inflammatory cytokines and neurological worsening in acute ischemic stroke. Stroke 2003 34 : 671 675.
9. Tarkowski E, Rosengren L, Blomstrand C, et al. Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. Stroke 1995 26 : 1393 1398.
10. Acalovschi D, Wiest T, Hartmann M, et al. Multiple levels of regulation of the interleukin-6 system in stroke. Stroke 2003 34 : 1864 1869.
11. Perini F, Morra M, Alecci M, Galloni E, Marchi M, Toso V. Temporal profile of serum anti-inflammatory and pro-inflammatory interleukins in acute ischemic stroke patients. Neurological Sciences 2001 22 : 289 296.
12. Hoshi T, Kitagawa K, Yamagami H, Furukado S, Hougaku H, Hori M. Relations of serum high-sensitivity c-reactive protein and interleukin-6 levels with silent brain infarction. Stroke 2005 36 : 768 772.
13. Jenny NS, Arnold AM, Kuller LH, et al. Soluble intracellular adhesion molecule-1 is associated with cardiovascular disease risk and mortality in older adults. Journal of Thrombosis and Haemostasis 2006 4 : 107 113.
14. Rallidis LS, Vikelis M, Panagiotakos DB, et al. Inflammatory markers and in-hospital mortality in acute ischaemic stroke. Atherosclerosis 2000 189 : 193 197.
15. Smith CJ, Emsley HC, Gavin CM, et al. Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome. BMC Neurolgy 2004 4 : 1 8.
16. Waje-Andreassen U, Krakenes J, Ulvestad E, et al. IL-6: an early marker for outcome in acute ischemic stroke. Acta Neurologica Scandinavica 2005 111 : 360 365.
17. Chamorro A, Revilla M, Obach V, Vargas M, Planas AM. The -174G/C polymorphism of the interleukin 6 gene is a hallmark of lacunar stroke and not other ischemic stroke phenotypes. Cerebrovascular Diseases 2005 19 : 91 95.
18. Davalos A, Cendra E, Teruel J, Martinez M, Genis D. Deteriorating ischemic stroke: risk factors and prognosis. Neurology 1990 40 : 1865 1869.
19. Herndon R. Handbook of Neurologic Rating Scales. New York : Demos Vermande, 1997.
20. Duncan PW, Lai SM, Bode RK, Perera S, DeRosa J. Stroke Impact Scale-16: a brief assessment of physical function. Neurology 2003 60 : 291 296.
21. Castellanos M, Castillo J, Garcia MM, et al. Inflammation-mediated damage in progressing lacunar infarctions: a potential therapeutic target. Stroke 2002 33 : 982 987.
22. Akyol A, Ozkul A, Yenisey C, Kiylioglu N. The relationship between protein C, protein S and cytokines in acute ischemic stroke. Neuroimmunomodulation 2006 13 : 187 193.
23. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. The New England Journal of Medicine 2000 342 : 836 843.
24. Sotgiu S, Zanda B, Marchetti B, et al. Inflammatory biomarkers in blood of patients with acute brain ischemia. European Journal of Neurology 2006 13 : 505 513.
25. Smith CJ, Emsley HC, Vail A, et al. Variability of the systemic acute phase response after ischemic stroke. Journal of The Neurological Sciences 2006 251 : 77 81.
26. Shyu KG, Chang H, Lin CC. Serum levels of intercellular adhesion molecule-1 and E-selectin in patients with acute ischaemic stroke. Journal of Neurolology 1997 244 : 90 93.
27. Fassbender K, Mossner R, Motsch L, Kischka U, Grau A, Hennerici M. Circulating selectin- and immunoglobulin-type adhesion molecules in acute ischemic stroke. Stroke 1995 26 : 1361 1364.
28. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000 101 : 1767 1772.
29. Tanne D, Haim M, Boyko V, et al. Soluble intercellular adhesion molecule-1 and risk of future ischemic stroke: a nested case-control study from the bezafibrate infarction prevention (BIP) study cohort. Stroke 2002 33 : 2182 2186.
30. Kim JS, Yoon SS, Kim YH, Ryu JS. Serial measurement of interleukin-6, transforming growth factor-ß, and S-100 protein in patients with acute stroke. Stroke 1996 27 : 1553 1557.
31. Menezes NM, Ay H, Zhu MW, et al. The real estate factor: quantifying the impact of infarct location on stroke severity. Stroke 2007 38 : 194 197.